These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 36415839)

  • 1. Transient Leukopenia Induced by Combination Therapy for Severe SARS-CoV-2 Pneumonia.
    Sullivan S; Leelaviwat N; Davalos J; Evans A; Abdelnabi M; Mittal N
    Eur J Case Rep Intern Med; 2022; 9(10):003636. PubMed ID: 36415839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient leukocytopenia following combination therapy for COVID-19.
    Tsuchiya K; Fujisawa T; Mochizuka Y; Takuma S; Oishi K; Endo Y; Tanaka Y; Fukada A; Watanabe H; Katsumata M; Aoshima Y; Inoue Y; Suzuki Y; Karayama M; Hozumi H; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
    Respir Investig; 2022 Jan; 60(1):158-161. PubMed ID: 34649811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Retrospective Study of Dexamethasone, Remdesivir, and Baricitinib in Severe COVID-19.
    Ngo DQ; Hamid K; Rana H; Cardinale M; Frenia D; Ghani N; Redel H
    Can J Infect Dis Med Microbiol; 2022; 2022():9209618. PubMed ID: 35845297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with predicted body weight-based dexamethasone, remdesivir, and baricitinib in patients with COVID-19 pneumonia: A single-center retrospective cohort study during 5th wave in Japan.
    Hirasawa Y; Terada J; Shionoya Y; Fujikawa A; Isaka Y; Takeshita Y; Kinouchi T; Koshikawa K; Tajima H; Kinoshita T; Tada Y; Tatsumi K; Tsushima K
    Respir Investig; 2023 Jul; 61(4):438-444. PubMed ID: 37119744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report study of the first five COVID-19 patients treated with remdesivir in France.
    Dubert M; Visseaux B; Isernia V; Bouadma L; Deconinck L; Patrier J; Wicky PH; Le Pluart D; Kramer L; Rioux C; Le Hingrat Q; Houhou-Fidouh N; Yazdanpanah Y; Ghosn J; Lescure FX
    Int J Infect Dis; 2020 Sep; 98():290-293. PubMed ID: 32619764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Baricitinib in Combination With Remdesivir and Steroid in COVID-19 Treatment: A Multicenter Retrospective Study.
    So JM; Umeh C; Noriega S; Stratton E; Aseri M; Gupta RC
    Cureus; 2021 Dec; 13(12):e20620. PubMed ID: 35106192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Remdesivir in kidney transplant patients with SARS-CoV-2 pneumonia].
    Cacho J; Burgos E; Molina M; Villegas A; Pérez M; Cañas L; Taco O; Juega J; Lauzurica R
    Nefrologia; 2022; 42(3):311-317. PubMed ID: 34305226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.
    Sharma A; Sharma C; Raina S; Singh B; Dadhwal DS; Dogra V; Gupta S; Bhandari S; Sood V
    Trials; 2021 Jul; 22(1):451. PubMed ID: 34266452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocilizumab and Baricitinib for Recovery From Acute Exacerbation of Combined Pulmonary Fibrosis and Emphysema Secondary to COVID-19 Infection: A Case Report.
    Kai Y; Matsuda M; Suzuki K; Kasamatsu T; Kajita A; Uno K; Muro S
    Cureus; 2022 Mar; 14(3):e23411. PubMed ID: 35481309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Japanese rapid/living recommendations on drug management for COVID-19: updated guidelines (September 2021).
    Yamakawa K; Yamamoto R; Terayama T; Hashimoto H; Ishihara T; Ishimaru G; Imura H; Okano H; Narita C; Mayumi T; Yasuda H; Yamada K; Yamada H; Kawasaki T; Shime N; Doi K; Egi M; Ogura H; Aihara M; Kushimoto S; Nishida O;
    Acute Med Surg; 2021; 8(1):e706. PubMed ID: 34815889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Combination Therapy With The JAK Inhibitor Baricitinib In The Treatment of COVID-19.
    Thoms BL; Gosselin J; Libman B; Littenberg B; Budd R
    Res Sq; 2021 Sep; ():. PubMed ID: 34518834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort.
    Karolyi M; Gruebl A; Omid S; Saak M; Pawelka E; Hoepler W; Kelani H; Kuran A; Laferl H; Ott C; Pereyra D; Santol J; Seitz T; Traugott M; Assinger A; Wenisch C; Zoufaly A
    Infection; 2023 Aug; 51(4):851-858. PubMed ID: 36083403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Combination Therapy with the JAK Inhibitor Baricitinib in the Treatment of COVID-19.
    Thoms BL; Gosselin J; Libman B; Littenberg B; Budd RC
    SN Compr Clin Med; 2022; 4(1):42. PubMed ID: 35079694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis.
    Sodani P; Mucci L; Girolimetti R; Tedesco S; Monaco F; Campanozzi D; Brunori M; Maltoni S; Bedetta S; Di Carlo AM; Candoli P; Mancini M; Rebonato A; D'Adamo F; Capalbo M; Frausini G
    Respir Med Case Rep; 2020; 31():101115. PubMed ID: 32670785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-Associated Pulmonary Aspergillosis in a Patient Treated With Remdesivir, Dexamethasone, and Baricitinib: A Case Report.
    Shimada A; Ohnaka S; Kubo K; Nakashima M; Nagai A
    Cureus; 2022 Apr; 14(4):e23755. PubMed ID: 35518522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
    Maes B; Bosteels C; De Leeuw E; Declercq J; Van Damme K; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B
    Trials; 2020 Jun; 21(1):468. PubMed ID: 32493441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe SARS-CoV-2 infection in a 32-week pregnant woman treated with Remdesivir-Dexamethasone combination therapy: A case report.
    Alavi SMA; Bahrami S; Najafian M; Hoori M
    Clin Case Rep; 2022 Aug; 10(8):e6241. PubMed ID: 35979383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A COVID-19 pandemic guideline in evidence-based medicine.
    Shamsoddin E
    Evid Based Dent; 2020 Jun; 21(2):71-73. PubMed ID: 32591667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.